14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today KOOL ranks #13253 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cesca Therapeutics Inc. Stock Forecast NASDAQ:KOOL

$1.23 (0%)

Volume: 45k

Closed: Dec 08, 2021

Hollow Logo Score: -2.966

Cesca Therapeutics Inc. Stock Forecast

$1.23 (0%)

Volume: 45k

Closed: Dec 08, 2021

Score Hollow Logo -2.966
Which way will KOOL go? Request

KOOL Stock Risk

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0499 between high and low, or 4.16%. For the last week the stock has had a daily average volatility of 8.06%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 39 and the stock is currently not being overbought or oversold

Red day on Wednesday for Cesca Therapeutics Inc. stock after losing 0%
(Updated on Dec 08, 2021)


Sell candidate since 2021-12-08

No changes to the price of Cesca Therapeutics Inc. stock on the last trading day (Wednesday, 8th Dec 2021). During the day the stock fluctuated 4.16% from a day low at $1.20 to a day high of $1.25. The price has fallen in 6 of the last 10 days and is down by -3.91% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -46.20% during the next 3 months and, with a 90% probability hold a price between $0.56 and $0.73 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 12.84%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cesca Therapeutics Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.46. On a fall, the stock will find some support from the short-term average at $1.20. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss

Cesca Therapeutics Inc. finds support from accumulated volume at $1.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0499 between high and low, or 4.16%. For the last week the stock has had a daily average volatility of 8.06%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Cesca Therapeutics Inc. stock A Buy?

Cesca Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.966

Predicted Opening Price for Cesca Therapeutics Inc. of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$1.23 $1.23 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 8.06 %
Overall Risk: Very High High Medium Low Very Low
Volatility
8.06 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $1.34
Price: $1.23
Support: $1.21

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.28 3.79 %
1.26 2.24 %
1.25 1.28 %
Current price: 1.23
Support 1.21 -1.82 %
1.20 -2.78 %
1.18 -4.33 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 1.51 22.76 %
1.50 21.95 %
1.34 8.94 %
Current price 1.23
Support 1.21 -1.63%
1.20 -2.44%
1.13 -8.13%

Click to get the best stock tips daily for free!

About Cesca Therapeutics Inc.

Cesca Therapeutics Cesca Therapeutics Inc. focuses on the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine in the United States and internationally. The company develops and manufactures automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. Its products include SurgWerks system, a proprietary system comprised ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT